Hypercoagulability and dyslipidemia in membranous nephropathy with anti-phospholipase A2 receptor antibodies
Saved in:
| Main Authors: | Michael Kitlinski, Zbigniew Heleniak, Alicja Dębska-Ślizień |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2441392 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy
by: Yunyun Liu, et al.
Published: (2024-12-01) -
Renal Dysfunction in Primary Aldosteronism: How, When, and Who?
by: Michael Kitlinski, et al.
Published: (2025-01-01) -
Recurrence of Phospholipase A2 Receptor–Associated Membranous Nephropathy in the Absence of Serum Anti-Phospholipase A2 Receptor Antibodies Reappearance
by: Ilias Bensouna, et al.
Published: (2025-03-01) -
Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
by: Keying Fu, et al.
Published: (2022-01-01) -
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation
by: Marion Cremoni, et al.
Published: (2024-12-01)